Pharmaceuticals

A new drug slows insulin-dependent diabetic deterioration and has sped up development of a complete remedy

The National Institutes of Health is investing $50 million into research on genetic and environmental factors underlying autism—news that was eclipsed by President Donald Trump’s recent controversial claims about acetaminophen

The Trump administration is backing leucovorin as a treatment for autism, despite limited evidence. Some doctors and researchers are concerned

While our understanding of Alzheimer’s disease is far from complete, the latest therapies, and others in more than 100 clinical trials, offer new hope

New Alzheimer’s drugs known as anti-amyloid therapies may slow disease progression—but they also carry serious risks, including brain bleeds and strokelike symptoms

A hormone-free pill, called YCT-529, that temporarily stops sperm production by blocking a vitamin A metabolite has just concluded its first safety trial in humans, getting a step closer to increasing male contraceptive options

GLP-1 drugs currently being tested in China target complications associated with obesity such as heart disease, fatty liver disease and type 2 diabetes

Drugs that target wakefulness, molecules in cannabis and wearable devices that modulate brain activity could help people with insomnia

When insomnia took hold of this journalist, she relied on her science reporting to find a medication that (mostly) worked

Results from a phase 3 clinical trial suggest that taking ubrogepant at the first sign of an oncoming migraine can prevent preheadache fatigue and light sensitivity

Some users of GLP-1 weight-loss drugs have been reporting strange changes in food preferences, such as a new dislike for meats or fried foods, and scientists are beginning to figure out why

Some experts say oral versions of popular weight-loss drugs such as Wegovy could offer people more flexibility and accessibility. What’s keeping the pills from taking off?